Missense_NN
mutation_NN
in_IN
exon_NN
7_CD
of_IN
the_DT
common_JJ
gamma_NN
chain_NN
gene_NN
causes_VBZ
a_DT
moderate_JJ
form_NN
of_IN
X-linked_JJ
combined_JJ
immunodeficiency_NN
._.

Clinical_JJ
and_CC
immunologic_JJ
features_NNS
of_IN
a_DT
recently_RB
recognized_VBN
X-linked_JJ
combined_JJ
immunodeficiency_NN
disease_NN
-LRB-_-LRB-
XCID_NN
-RRB-_-RRB-
suggested_VBD
that_IN
XCID_NN
and_CC
X-linked_JJ
severe_JJ
combined_JJ
immunodeficiency_NN
-LRB-_-LRB-
XSCID_NN
-RRB-_-RRB-
might_MD
arise_VB
from_IN
different_JJ
genetic_JJ
defects_NNS
._.

The_DT
recent_JJ
discovery_NN
of_IN
mutations_NNS
in_IN
the_DT
common_JJ
gamma_NN
chain_NN
-LRB-_-LRB-
gamma_NN
c_NN
-RRB-_-RRB-
gene_NN
,_,
a_DT
constituent_NN
of_IN
several_JJ
cytokine_NN
receptors_NNS
,_,
in_IN
XSCID_NN
provided_VBD
an_DT
opportunity_NN
to_TO
test_VB
directly_RB
whether_IN
a_DT
previously_RB
unrecognized_JJ
mutation_NN
in_IN
this_DT
same_JJ
gene_NN
was_VBD
responsible_JJ
for_IN
XCID_NN
._.

The_DT
status_NN
of_IN
X_NN
chromosome_NN
inactivation_NN
in_IN
blood_NN
leukocytes_NNS
from_IN
obligate_JJ
carriers_NNS
of_IN
XCID_NN
was_VBD
determined_VBN
from_IN
the_DT
polymorphic_JJ
,_,
short_JJ
tandem_JJ
repeats_NNS
-LRB-_-LRB-
CAG_NN
-RRB-_-RRB-
,_,
in_IN
the_DT
androgen_NN
receptor_NN
gene_NN
,_,
which_WDT
also_RB
contains_VBZ
a_DT
methylation-sensitive_JJ
HpaII_NN
site_NN
._.

As_IN
in_IN
XSCID_NN
,_,
X-chromosome_NN
inactivation_NN
in_IN
obligate_JJ
carriers_NNS
of_IN
XCID_NN
was_VBD
nonrandom_JJ
in_IN
T_NN
and_CC
B_NN
lymphocytes_NNS
._.

In_IN
addition_NN
,_,
X_NN
chromosome_NN
inactivation_NN
in_IN
PMNs_NNS
was_VBD
variable_JJ
._.

Findings_NNS
from_IN
this_DT
analysis_NN
prompted_VBD
sequencing_NN
of_IN
the_DT
gamma_NN
c_NN
gene_NN
in_IN
this_DT
pedigree_NN
._.

A_DT
missense_NN
mutation_NN
in_IN
the_DT
region_NN
coding_VBG
for_IN
the_DT
cytoplasmic_JJ
portion_NN
of_IN
the_DT
gamma_NN
c_NN
gene_NN
was_VBD
found_VBN
in_IN
three_CD
affected_VBN
males_NNS
but_CC
not_RB
in_IN
a_DT
normal_JJ
brother_NN
._.

Therefore_RB
,_,
this_DT
point_NN
mutation_NN
in_IN
the_DT
gamma_NN
c_NN
gene_NN
leads_VBZ
to_TO
a_DT
less_RBR
severe_JJ
degree_NN
of_IN
deficiency_NN
in_IN
cellular_JJ
and_CC
humoral_JJ
immunity_NN
than_IN
that_DT
seen_VBN
in_IN
XSCID_NN
._.

